- Home
- / Waverley Pharma
Waverley Pharma
Stock Price
$0
2024-10-29
Market Capitalization
$810 K
2024-10-29
Revenue
$1.3 M
FY, 2025
Waverley Pharma Summary
Company Summary
- Overview
- Waverley Pharma is a biopharmaceutical company that researches, develops, and commercializes cancer therapeutics. It focuses on generic oncology injectable products.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- Winnipeg, CA | view all locations
- Cybersecurity rating
Table of Contents
Key People
Albert D. Friesen, Director
P. Marcus Enns, Director
LocationsView all
1 location detected
Winnipeg, MB HQ
Canada
1250 Waverley St #4
Waverley Pharma Financials
Summary Financials
- Revenue (Q1, 2026)
- $C287.0K
- Gross profit (Q1, 2026)
- $C113.0K
- Net income (Q1, 2026)
- ($C165.0K)
- Cash (Q1, 2026)
- $C69.0K
- EBIT (Q1, 2026)
- ($C123.0K)
- Enterprise value
- $4.1M